📰 Tim Mccarthy News

Page 44 - Tim Mccarthy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tim Mccarthy. Real-time updates on events, politics, business and more.

Amryt Announces Positive Interim Analysis Data From Open Label Phase of EASE Phase 3 Trial in EB

March 26, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United States New South Wales Saudi Arabia Patrick Bursey Rory Nealon Hypercholesterolaemia Ho

Source: apnews.com

Mitchell to step down as Orland Park police chief

March 24, 2022

Joseph Mitchell is stepping down as police chief of Orland Park to pursue a new opportunity heading the Wilmington police.

Village Of Orland Park United States Lewis University Cook County Orland Park Eastern Illinois University

Source: nwitimes.com

Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

March 23, 2022

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

United States Sergio Traversa Tim Mccarthy Relmada Therapeutics Inc Clinical Research Program Company Phase

Source: prnewswire.com

Immutep To Present Biomarker And Multivariate Analysis From Phase IIb AIPAC Study In Metastatic Breast Cancer At ESMO's Breast Cancer Congress 2022

March 18, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Baden Wüberg United States New South Wales Frederik Marm Tim Mccarthy Immutep Limited

Source: apnews.com

BioLineRx Reports Year-End 2021 Financial Results and Provides Corporate Update

March 16, 2022

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial...

United States Moran Meir Tim Mccarthy Philip Serlin Exchange Commission American Society Of Hematology

Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Relmada Therapeutics to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 23, 2022

March 16, 2022

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Tim Mccarthy Relmada Therapeutics Inc Clinical Research Program Securities Exchange Relmada Therapeutics Conference Call

Source: prnewswire.com

Relmada Therapeutics to Participate in Fireside Chats at Two Upcoming Healthcare Events

March 10, 2022

/PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Maged Shenouda Tim Mccarthy Sergio Traversa Needham Company Relmada Therapeutics Inc Clinical Research Program

Source: prnewswire.com